ArticlePloS one2026
HIF-1α inhibits the TLR4/NF-κB signaling pathway and modulates intestinal flora in diarrhea-predominant irritable bowel syndrome.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study explored the regulatory effects of hypoxia-inducible factor-1α (HIF-1α) on the TLR4/NF-κB pathway and intestinal flora in diarrhea-predominant irritable bowel syndrome (IBS-D).
methodsTwenty-eight Wistar rats were randomized into four groups: model (n = 13), blank control (n = 5), HIF-1α upregulation (n = 5), and HIF-1α downregulation (n = 5). The IBS-D model group received combined acute and chronic stress stimulation for disease induction. On the basis of identical stress intervention, the HIF‑1α upregulation group was additionally exposed to a hypobaric hypoxic chamber, while the HIF‑1α downregulation group underwent intraperitoneal administration of the HIF‑1α antagonist 2‑methoxyestradiol to achieve targeted modulation of HIF‑1α expression.the control group was fed conventionally. Two model rats were euthanized on days 0, 7, 14, 21 to analyze colonic HIF-1α, TLR4 and NF-κB, and feces from the remaining 5 model rats were gathered on days 0, 7, 14, 21, 28 for 16S rRNA sequencing. Gastrointestinal symptoms, mucosal integrity and molecular expression were assessed after 28 days.
resultsAn IBS-D model was successfully established. HIF-1α expression in the model group increased progressively, while TLR4/NF-κB levels fluctuated but showed an overall increase. The levels of all three markers were significantly higher than those in the control group(P < 0.05). The HIF-1α downregulation group exhibited more severe IBS-D symptoms and higher TLR4/NF-κB expressions than the upregulation group (P < 0.05). At the genus level, the abundance of Lachnospiraceae NK4A136 decreased, whereas the abundance of the Prevotellaceae NK3B31 group, Clostridia UCG - 014, UCG - 005, and Prevotellaceae UCG - 001 increased (P < 0.05).
conclusionUnder systemic hypobaric hypoxic stress, HIF-1α suppresses the TLR4/NF-κB signaling pathway and alleviates intestinal inflammatory responses. Concurrent intestinal hypoxia and inflammatory injury jointly interfere with normal commensal colonization, accompanied by altered gut microbial composition in IBS-D model rats. Changes in HIF-1α levels are biologically correlated with shifts in intestinal microbiota, though direct causal regulation of gut flora by HIF-1α remains to be verified in further experiments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.